Scientists test drug Mix-Ups for future cancer therapy
NCT ID NCT07395024
Summary
This early-stage study aims to understand how three common medications (fluconazole, itraconazole, and carbamazepine) affect the body's processing of a new experimental drug called ASP3082. ASP3082 is being developed to target a specific genetic mutation found in some solid tumors. The study involves 54 healthy adults who will receive ASP3082 alone and in combination with the other drugs to measure any changes in drug levels and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Parexel
RECRUITINGBaltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.